- gsearch

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

- gsearch

Search Results

Narrow Results:

2021 1

Journal Article 1

1 Results

Refine Results

All Collections

Refine Results:

All Collections

Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV

CITE Title : Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV Personal Author(s) : Kalkowska, Dominika A.;Thompson, Kimberly M.; Published Date : 2 2021;2-2021; Source : Risk Anal. 41(2):312-319 URL : https://stacks.cdc.gov/view/cdc/153687 Kalkowska, Dominika A. and Thompson, Kimberly M. (2021). Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV. 41(2). Kalkowska, Dominika A. and Thompson, Kimberly M. "Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV" 41, no. 2 (2021) Kalkowska, Dominika A. and Thompson, Kimberly M. "Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV" vol. 41, no. 2, 2021 Export RIS Citation Information.

:

Kalkowska, Dominika A. ;

Thompson, Kimberly M.

2 2021 | Risk Anal. 41(2):312-319

:

Globally coordinated cessation of all three serotypes of oral poliovirus vaccine (OPV) represents a critical part of a successful polio endgame, which...

To see more results, try removing search filters or changing the search terms